165
Participants
Start Date
November 30, 2010
Primary Completion Date
August 31, 2012
Study Completion Date
August 31, 2012
Factor VIII (rFVIIIFc)
Advate®
Research Site, Auckland
Research Site, Vienna
Research Site, Brussels
Research Site, Palmerston North
Research Site, Christchurch
Research Site, Philadelphia
Research Site, Philadelphia
Research Site, Gothenburg
Research Site, Ramat Gan
Research Site, Lyon
Research Site, Little Rock
Research Site, Los Angeles
Research Site, Orange
Research Site, Sacramento
Research Site, San Diego
Research Site, Washington D.C.
Research Site, Indianapolis
Research Site, Iowa City
Research Site, Louisville
Research Site, New Orleans
Research Site, Boston
Research Site, East Lansing
Research Site, Las Vegas
Research Site, New York
Research Site, Chapel Hill
Research Site, Pittsburgh
Research Site, Houston
Research Site, Salt Lake City
Research Site, Seattle
Research Site, Camperdown
Research Site, Adelaide
Research Site, Perth
Research Site, Campinas
Research Site, Toronto
Research Site, Bonn
Research Site, Berlin
Research Site, Hong Kong
Research Site, Bangalore
Research Site, Pune
Research Site, New Delhi
Research Site, Ludhiana
Research Site, Vellore
Research Site, Florence
Research Site, Milan
Research Site, Vicenza
Research Site, Kashihara-shi
Research Site, Kawasaki-shi
Research Site, Kitakyushu-shi
Research Site, Nagoya
Research Site, Shinjuku-ku
Research Site, Suginami-ku
Research Site, Johannesburg Parktown
Research Site, Cape Town
Research Site, Barcelona
Research Site, Madrid
Research Site, Zurich
Research Site, Calgary
Research Site, Vancouver
Research Site, Basingstoke
Research Site, Cambridge
Research Site, Glasgow
Research Site, London
Research Site, London
Research Site, London
Lead Sponsor
Collaborators (1)
Swedish Orphan Biovitrum
INDUSTRY
Bioverativ Therapeutics Inc.
INDUSTRY